Bacteria-related changes in host DNA methylation and the risk for CRC

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–15. doi:10.3322/caac.20107.
   PubMed Web of Science ®Google Scholar
• Foulkes WD. Inherited susceptibility to common cancers. N Engl J Med. 2008;359(20):2143–2153. doi:10.1056/NEJMra0802968.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027–1031. doi:10.1038/nature05414.
   PubMed Web of Science ®Google Scholar
• Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022–1023. doi:10.1038/4441022a.
   PubMed Web of Science ®Google Scholar
• Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith K, Preisinger A, Hedge P, McKechnie D, et al. Identification of FAP locus genes from chromosome 5q21. Science. 1991;253(5020):661–665. doi:10.1126/science.1651562.
   PubMed Web of Science ®Google Scholar
• Kinzler KW, Nilbert MC, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger A, Hedge P, Markham A, et al. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science. 1991;251(4999):1366–1370. doi:10.1126/science.1848370.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Nishisho I, Kinzler KW, Vogelstein B, Miyoshi Y, Miki Y, Ando H, Horii A, Nagase H. Mutations of the adenomatous polyposis coli gene in familial polyposis coli patients and sporadic colorectal tumors.. Princess Takamatsu Symposia. 1991;22:285–292.
   PubMedGoogle Scholar
• Nakamura Y, Nishisho I, Kinzler KW, Vogelstein B, Miyoshi Y, Miki Y, ANDO H, HORII A. Mutations of the APC(Adenomatous Polyposis Coli) Gene in FAP(Familial Polyposis Coli) Patients and in Sporadic Colorectal Tumors.. Tohoku J Exp Med. 1992;168(2):141–147. doi:10.1620/tjem.168.141.
   PubMed Web of Science ®Google Scholar
• Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW. APC mutations occur early during colorectal tumorigenesis. Nature. 1992;359(6392):235–237. doi:10.1038/359235a0.
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet. 1993;9(4):138–141. doi:10.1016/0168-9525(93)90209-Z.
   PubMed Web of Science ®Google Scholar
• Kinzler KW, Vogelstein B. Landscaping the cancer terrain. Science. 1998;280:1036–1037. doi:10.1126/science.280.5366.1036.
   PubMed Web of Science ®Google Scholar
• Burton-Chase AM, Hovick SR, Peterson SK, Marani SK, Vernon SW, Amos CI, Frazier ML, Lynch PM, Gritz ER. Changes in screening behaviors and attitudes toward screening from pre-test genetic counseling to post-disclosure in Lynch syndrome families. Clin Genet. 2013;83(3):215–220. doi:10.1111/cge.12091.
   PubMed Web of Science ®Google Scholar
• Guinney J, Dienstmann R, Wang X, de Reynies A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda G, Angelino P. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21(11):1350–1356. doi:10.1038/nm.3967.
   PubMed Web of Science ®Google Scholar
• The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nat Med. 2012;487(7407):330–337. doi:10.1038/nature11252.
   Google Scholar
• Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, Kolodner R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 1997;57:808–811.
   PubMed Web of Science ®Google Scholar
• Parsons MT, Buchanan DD, Thompson B, Young JP, Spurdle AB. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification. J Med Genet. 2012;49(3):151–157. doi:10.1136/jmedgenet-2011-100714.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhang Y. Role of Mammalian DNA Methyltransferases in Development. Annu Rev Biochem. 2020 Jun 20;89:135–158. doi: 10.1146/annurev-biochem-103019-102815.
   PubMed Web of Science ®Google Scholar
• Epsztejn-Litman S, Feldman N, Abu-Remaileh M, Shufaro Y, Gerson A, Ueda J, Deplus R, Fuks F, Shinkai Y, Cedar H. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat Struct Mol Biol. 2008;15(11):1176–1183. doi:10.1038/nsmb.1476.
   PubMed Web of Science ®Google Scholar
• Feldman N, Gerson A, Fang J, Li E, Zhang Y, Shinkai Y, Cedar H, Bergman Y. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat Cell Biol. 2006;8(2):188–194. doi:10.1038/ncb1353.
   PubMed Web of Science ®Google Scholar
• Orlanski S, Labi V, Reizel Y, Spiro A, Lichtenstein M, Levin-Klein R, Koralov SB, Skversky Y, Rajewsky K, Cedar H. Tissue-specific DNA demethylation is required for proper B-cell differentiation and function. Proc Natl Acad Sci U S A. 2016;113(18):5018–5023. doi:10.1073/pnas.1604365113.
   PubMed Web of Science ®Google Scholar
• Lu F, Liu Y, Jiang L, Yamaguchi S, Zhang Y. Role of Tet proteins in enhancer activity and telomere elongation. Genes Dev. 2014;28(19):2103–2119. doi:10.1101/gad.248005.114.
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, Malinge S, Yao J, Kilpivaara O, Bhat R, et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood. 2009;114(1):144–147. doi:10.1182/blood-2009-03-210039.
   PubMed Web of Science ®Google Scholar
• Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet. 2018;19(6):371–384. doi:10.1038/s41576-018-0004-3.
   PubMed Web of Science ®Google Scholar
• Dor Y, Cedar H. Principles of DNA methylation and their implications for biology and medicine. Lancet. 2018;392(10149):777–786. doi:10.1016/S0140-6736(18)31268-6.
   PubMed Web of Science ®Google Scholar
• Horvath S. DNA methylation age of human tissues and cell types. Genome Biology. 1994;145:R115. doi:10.1186/gb-2013-14-10-r115.
   Web of Science ®Google Scholar
• Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, Klotzle B, Bibikova M, Fan J-B, Gao Y, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 2013;49(2):359–367. doi:10.1016/j.molcel.2012.10.016.
   PubMed Web of Science ®Google Scholar
• Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, Hou L, Baccarelli AA, Stewart JD, Li Y, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10(4):573–591. doi:10.18632/aging.101414.
   PubMedGoogle Scholar
• Murabito JM, Rong J, Lunetta KL, Huan T, Lin H, Zhao Q, Freedman JE, Tanriverdi K, Levy D, Larson MG, et al. Cross-sectional relations of whole-blood miRNA expression levels and hand grip strength in a community sample. Aging Cell. 2017;16(4):888–894. doi:10.1111/acel.12622.
   PubMed Web of Science ®Google Scholar
• Mills JA, Beach SRH, Dogan M, Simons RL, Gibbons FX, Long JD, et al. A Direct Comparison of the Relationship of Epigenetic Aging and Epigenetic Substance Consumption Markers to Mortality in the Framingham Heart Study. Genes (Basel). 2019 Jan 15;10(1):51. doi: 10.3390/genes10010051.
   Google Scholar
• Philibert RA, Dogan MV, Mills JA, Long JD. AHRR Methylation is a Significant Predictor of Mortality Risk in Framingham Heart Study. J Insur Med. 2019;48(1):79–89. doi:10.17849/insm-48-1-1-11.1. Epub 2019 Oct 16.
   Google Scholar
• Dhingra R, Nwanaji-Enwerem JC, Samet M, Ward-Caviness CK. DNA Methylation Age—Environmental Influences, Health Impacts, and Its Role in Environmental Epidemiology. Curr Environ Health Rep. 2019;10:317–327. doi:10.1007/s40572-018-0203-2.
   Google Scholar
• Zheng Y, Joyce BT, Colicino E, Liu L, Zhang W, Dai Q, Shrubsole MJ, Kibbe WA, Gao T, Zhang Z, et al. Blood Epigenetic Age may Predict Cancer Incidence and Mortality. EBioMedicine. 2016;5:68–73. doi:10.1016/j.ebiom.2016.02.008.
   PubMed Web of Science ®Google Scholar
• Dugue P-A, Bassett JK, Joo JE, Jung C-H, Ming Wong E, Moreno-Betancur M, Schmidt D, Makalic E, Li S, Severi G, et al. DNA methylation-based biological aging and cancer risk and survival: pooled analysis of seven prospective studies. Int J Cancer. 2018;142(8):1611–1619. doi:10.1002/ijc.31189.
   PubMed Web of Science ®Google Scholar
• Zhu T, Gao Y, Wang J, Li X, Shang S, Wang Y, Guo S, Zhou H, Liu H, Sun D, et al. CancerClock: A DNA Methylation Age Predictor to Identify and Characterize Aging Clock in Pan-Cancer. Front Bioeng Biotechnol. 2019;7:388. doi:10.3389/fbioe.2019.00388.
   PubMed Web of Science ®Google Scholar
• Toyota M, Ho C, Ahuja N, KW J, Li Q, Ohe-Toyota M. The proto CpG island methylator phenotype of sessile serrated adenomas/polyps. Epigenetics. 2018;13(10–11):1088–1105. doi:10.1080/15592294.2018.1543504.
   PubMed Web of Science ®Google Scholar
• Okugawa Y, Grady WM, Goel A. Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. Gastroenterology 2015; 149:1204–25 e12.
   PubMed Web of Science ®Google Scholar
• Parker HR, Orjuela S, Martinho Oliveira A, Cereatti F, Sauter M, Heinrich H, et al. The proto CpG island methylator phenotype of sessile serrated adenomas/polyps. Epigenetics 2018; 13:1088–105.
   PubMed Web of Science ®Google Scholar
• Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, Thibodeau SN. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.. Cancer Res. 1998;58:3455–3460.
   PubMed Web of Science ®Google Scholar
• Emran AA, Chatterjee A, Rodger EJ, Tiffen JC, Gallagher SJ, Eccles MR, Hersey P. Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy. Trends Immunol. 2019;40(4):328–344. doi:10.1016/j.it.2019.02.004.
   PubMed Web of Science ®Google Scholar
• Joensuu EI, Nieminen TT, Lotsari JE, Pavicic W, Abdel-Rahman WM, Peltomaki P. Methyltransferase expression and tumor suppressor gene methylation in sporadic and familial colorectal cancer. Genes Chromosomes Cancer. 2015;54(12):776–787. doi:10.1002/gcc.22289.
   PubMed Web of Science ®Google Scholar
• Ng JM, Yu J. Promoter Hypermethylation of Tumour Suppressor Genes as Potential Biomarkers in Colorectal Cancer. Int J Mol Sci. 2015;16(2):2472–2496. doi:10.3390/ijms16022472.
   PubMed Web of Science ®Google Scholar
• O’Connell MR, Sarkar S, Luthra GK, Okugawa Y, Toiyama Y, Gajjar AH, Qiu S, Goel A, Singh P. Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: clinical Implications. Scientific Reports. 2015;5(1):14983. doi:10.1038/srep14983.
   PubMed Web of Science ®Google Scholar
• Bihl MP, Foerster A, Lugli A, Zlobec I. Characterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing. Journal of Translational Medicine. 2012;10(1):173. doi:10.1186/1479-5876-10-173.
   PubMed Web of Science ®Google Scholar
• Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB, Herman JG. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.. Cancer Res. 2000;60:129–133.
   PubMed Web of Science ®Google Scholar
• Liang T-J, Wang H-X, Zheng -Y-Y, Cao Y-Q, Wu X, Zhou X, Dong S-X. APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review. Oncotarget. 2017;8(28):46468–46479. doi:10.18632/oncotarget.17576.
   PubMedGoogle Scholar
• Baylin SB, Jones PA. A decade of exploring the cancer epigenome — biological and translational implications. Nat Rev Cancer. 2011;11(10):726–734. doi:10.1038/nrc3130.
   PubMed Web of Science ®Google Scholar
• Jung G, Hernandez-Illan E, Moreira L, Balaguer F, Goel A. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastroenterol Hepatol. 2020;17(2):111–130. doi:10.1038/s41575-019-0230-y.
   PubMed Web of Science ®Google Scholar
• Chatterjee A, Rodger EJ, Eccles MR. Epigenetic drivers of tumourigenesis and cancer metastasis. Semin Cancer Biol. 2018;51:149–159. doi:10.1016/j.semcancer.2017.08.004.
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr., Kinzler KW. Cancer genome landscapes. Science. 2013;339(6127):1546–1558. doi:10.1126/science.1235122.
   PubMed Web of Science ®Google Scholar
• Howell KJ, Kraiczy J, Nayak KM, Gasparetto M, Ross A, Lee C, Mak TN, Koo B-K, Kumar N, Lawley T. DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome. Gastroenterology. 2018;154(3):585–598. doi:10.1053/j.gastro.2017.10.007.
   PubMed Web of Science ®Google Scholar
• Kellermayer R, Balasa A, Zhang W, Lee S, Mirza S, Chakravarty A, Szigeti R, Laritsky E, Tatevian N, Smith CW, et al. Epigenetic maturation in colonic mucosa continues beyond infancy in mice. Hum Mol Genet. 2010;19(11):2168–2176. doi:10.1093/hmg/ddq095.
   PubMed Web of Science ®Google Scholar
• Tschurtschenthaler M, Kachroo P, Heinsen F-A, Adolph TE, Ruhlemann MC, Klughammer J, Offner FA, Ammerpohl O, Krueger F, Smallwood S, et al. Paternal chronic colitis causes epigenetic inheritance of susceptibility to colitis. Scientific Reports. 2016;6(1):31640. doi:10.1038/srep31640.
   PubMed Web of Science ®Google Scholar
• Nosho K, Shima K, Irahara N, Kure S, Baba Y, Kirkner GJ, Chen L, Gokhale S, Hazra A, Spiegelman D, et al. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer. Clin Cancer Res. 2009;15(11):3663–3671. doi:10.1158/1078-0432.CCR-08-2383.
   PubMed Web of Science ®Google Scholar
• Linhart HG, Lin H, Yamada Y, Moran E, Steine EJ, Gokhale S, Lo G, Cantu E, Ehrich M, He T, et al. Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev. 2007;21(23):3110–3122. doi:10.1101/gad.1594007.
   PubMed Web of Science ®Google Scholar
• Steine EJ, Ehrich M, Bell GW, Raj A, Reddy S, van Oudenaarden A,
   Google Scholar
• Sobhani I, Bergsten E, Couffin S, Amiot A, Nebbad B, Barau C, et al. Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures. Proc Natl Acad Sci U S A. 2019;116(48):24285–24295. doi:10.1073/pnas.1912129116.
   PubMed Web of Science ®Google Scholar
• Urbano A, Smith J, Weeks RJ, Chatterjee A. Gene-Specific Targeting of DNA Methylation in the Mammalian Genome. Cancers (Basel). 2019 Oct 9;11(10):1515. doi:10.3390/cancers11101515.
   Google Scholar
• Gounari F, Banks GR, Khazaie K, Jeggo PA, Holliday R. Gene reactivation: a tool for the isolation of mammalian DNA methylation mutants.. Genes Dev. 1987;1(9):899–912. doi:10.1101/gad.1.9.899.
   PubMed Web of Science ®Google Scholar
• Unnikrishnan A, Hadad N, Masser DR, Jackson J, Freeman WM, Richardson A. Revisiting the genomic hypomethylation hypothesis of aging. Ann N Y Acad Sci. 2018;1418(1):69–79. doi:10.1111/nyas.13533.
   PubMed Web of Science ®Google Scholar
• Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics. 2009;1(2):239–259. doi:10.2217/epi.09.33.
   PubMed Web of Science ®Google Scholar
• Heyn H, Li N, Ferreira HJ, Moran S, Pisano DG, Gomez A, Diez J, Sanchez-Mut JV, Setien F, Carmona FJ, et al. Distinct DNA methylomes of newborns and centenarians. Proc Natl Acad Sci U S A. 2012;109(26):10522–10527. doi:10.1073/pnas.1120658109.
   PubMed Web of Science ®Google Scholar
• Cheng Y-W, Idrees K, Shattock R, Khan SA, Zeng Z, Brennan CW, Paty P, Barany F. Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer. Int J Cancer. 2010;127(3):568–577. doi:10.1002/ijc.25086.
   PubMed Web of Science ®Google Scholar
• Weon JL, Potts PR. The MAGE protein family and cancer. Curr Opin Cell Biol. 2015;37:1–8. doi:10.1016/j.ceb.2015.08.002.
   PubMed Web of Science ®Google Scholar
• Kidane D, Chae WJ, Czochor J, Eckert KA, Glazer PM, Bothwell AL, Sweasy JB. Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol. 2014;49(2):116–139. doi:10.3109/10409238.2013.875514.
   PubMed Web of Science ®Google Scholar
• Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358(11):1148–1159. doi:10.1056/NEJMra072067.
   PubMed Web of Science ®Google Scholar
• Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, Weinberg RA, Jaenisch R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell. 1995;81(2):197–205. doi:10.1016/0092-8674(95)90329-1.
   PubMed Web of Science ®Google Scholar
• Gaudet F. Induction of tumors in mice by genomic hypomethylation. Science. 2003;300(5618):489–492. doi:10.1126/science.1083558.
   PubMed Web of Science ®Google Scholar
• Sakai E. Accumulation of aberrant DNA methylation during colorectal cancer development. World J Gastroenterol. 2014;20(4):978–987. doi:10.3748/wjg.v20.i4.978.
   PubMed Web of Science ®Google Scholar
• Sun D, Chen Y, Fang J-Y. Influence of the microbiota on epigenetics in colorectal cancer. National Science Review. 2019;6(6):1138–1148. doi:10.1093/nsr/nwy160.
   PubMed Web of Science ®Google Scholar
• Suter CM, Martin DI, Ward RL. Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue. Int J Colorectal Dis. 2004;19(2):95–101. doi:10.1007/s00384-003-0539-3.
   PubMed Web of Science ®Google Scholar
• Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, Corthier G, Van Nhieu JT, Furet JP, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One. 2011;6(1):e16393. doi:10.1371/journal.pone.0016393.
   PubMed Web of Science ®Google Scholar
• Duvallet C, Gibbons SM, Gurry T, Irizarry RA, Alm EJ. Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat Commun. 2017;8(1):1784. doi:10.1038/s41467-017-01973-8.
   PubMed Web of Science ®Google Scholar
• Sobhani I, Amiot A, Le Baleur Y, Levy M, Auriault ML, Van Nhieu JT, et al. Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease? Therapeutic advances in gastroenterology 2013; 6:215–229.
   Google Scholar
• Nakatsu G, Li X, Zhou H, Sheng J, Wong SH, Wu WK, et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat Commun. 2015;6(1):8727. doi:10.1038/ncomms9727.
   PubMed Web of Science ®Google Scholar
• Wong SH, Zhao L, Zhang X, Nakatsu G, Han J, Xu W, Xiao X, Kwong TNY, Tsoi H, Wu WKK, et al. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice. Gastroenterology. 2017;153(6):1621–33 e6. doi:10.1053/j.gastro.2017.08.022.
   PubMed Web of Science ®Google Scholar
• Remya KR, Chandran S, Mani S, John A, Ramesh P. Hybrid polycaprolactone/polyethylene oxide scaffolds with tunable fiber surface morphology, improved hydrophilicity and biodegradability for bone tissue engineering applications. J Biomater Sci Polym Ed. 2018;29(12):1444–1462. doi:10.1080/09205063.2018.1465664.
   PubMed Web of Science ®Google Scholar
• Sandler RS, Baron JA, Tosteson TD, Mandel JS, Haile RW. Rectal mucosal proliferation and risk of colorectal adenomas: results from a randomized controlled trial.. Cancer Epidemiol Biomarkers Prev. 2000;9:653–656.
   PubMed Web of Science ®Google Scholar
• Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy T, Chung D, Lochhead P, Hold G, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207–215. doi:10.1016/j.chom.2013.07.007.
   PubMed Web of Science ®Google Scholar
• Allen J, Sears CL. Impact of the gut microbiome on the genome and epigenome of colon epithelial cells: contributions to colorectal cancer development. Genome Med. 2019;11(1):11. doi:10.1186/s13073-019-0621-2.
   PubMed Web of Science ®Google Scholar
• Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin. Cell Host Microbe. 2013;14(2):195–206. doi:10.1016/j.chom.2013.07.012.
   PubMed Web of Science ®Google Scholar
• Attene-Ramos MS, Nava GM, Muellner MG, Wagner ED, Plewa MJ, Gaskins HR. DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells.. Environmental and Molecular Mutagenesis. 2010;51(4):304–314. doi:10.1002/em.20546.
   PubMed Web of Science ®Google Scholar
• Yazici C, Wolf PG, Kim H, Cross TWL, Vermillion K, Carroll T, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Gut. 2017 Nov;66(11):1983-1994. doi:10.1136/gutjnl-2016-313321.
   Google Scholar
• Ridlon JM, Wolf PG, Gaskins HR. Taurocholic acid metabolism by gut microbes and colon cancer. Gut Microbes. 2016;7(3):201–215. doi:10.1080/19490976.2016.1150414.
   PubMed Web of Science ®Google Scholar
• Maddocks OD, Scanlon KM, Donnenberg MS. An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins. MBio. 2018;19:e00152–13. doi:10.1128/mBio.00152-13.
   Web of Science ®Google Scholar
• Hackman P, Tannergard P, Osei-Mensa S, Chen J, Kane MF, Kolodner R, Lambert B, Hellgren D, Lindblom A. A human compound heterozygote for two MLH1 missense mutations. Nat Genet. 1997;17(2):135–136. doi:10.1038/ng1097-135.
   PubMed Web of Science ®Google Scholar
• Raisch J. Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. World J Gastroenterol. 2014;20(21):6560–6572. doi:10.3748/wjg.v20.i21.6560.
   PubMed Web of Science ®Google Scholar
• Wassenaar TM. E. Coli and Colorectal Cancer: A Complex Relationship that Deserves a Critical Mindset. Crit Rev Microbiol. 2018 Sep;44(5):619–632. doi:10.1080/1040841X.2018.1481013.
   Google Scholar
• Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, Geis AL, Wu X, DeStefano Shields CE, Hechenbleikner EM, Huso DL, et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science. 2018;359(6375):592–597. doi:10.1126/science.aah3648.
   PubMed Web of Science ®Google Scholar
• Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, Amiot A, Böhm J, Brunetti F, Habermann N, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Molecular Systems Biology. 2014;10(11):766. doi:10.15252/msb.20145645.
   PubMed Web of Science ®Google Scholar
• Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. The ISME journal 2012;6:320–329.
   Google Scholar
• O'Keefe SJ, Li JV, Lahti L, Ou J, et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun. 2015;6(1):6342. doi:10.1038/ncomms7342.
   PubMed Web of Science ®Google Scholar
• Pan W-H, Sommer F, Falk-Paulsen M, Ulas T, Best P, Fazio A, Kachroo P, Luzius A, Jentzsch M, Rehman A, et al. Exposure to the gut microbiota drives distinct methylome and transcriptome changes in intestinal epithelial cells during postnatal development. Genome Med. 2018;10(1):27. doi:10.1186/s13073-018-0534-5.
   PubMed Web of Science ®Google Scholar
• Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell pro-tection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol. 2001;167(3):1609–1616. doi: 10.4049/jimmunol.167.3.1609.
   Google Scholar
• Takahashi K, Sugi Y, Nakano K, Tsuda M, Kurihara K, Hosono A, Kaminogawa S. Epigenetic control of the host gene by commensal bacteria in large intestinal epithelial cells. J Biol Chem. 2011;286(41):35755–35762. doi:10.1074/jbc.M111.271007.
   PubMed Web of Science ®Google Scholar
• Liu B, Nicolaides NC, Markowitz S, Willson JK, Parsons RE, Jen J, Papadopolous N, Peltomäki P, de la Chapelle A, Hamilton SR. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet. 1995;9(1):48–55. doi:10.1038/ng0195-48.
   PubMed Web of Science ®Google Scholar
• Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-4.Sep 29;313(5795):1960–functional genes of the MMR system, mimics M1964. doi:10.1126/science.1129139.
   Google Scholar
• Kroemer G, Galluzzi L, Zitvogel L, Fridman WH. Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy? Oncoimmunology. 2015;4(7):e1058597. doi:10.1080/2162402X.2015.1058597.
   PubMed Web of Science ®Google Scholar
• Llosa NJ, Cruise M, Tam A, Wicks EC, Hechenbleikner EM, Taube JM, Blosser RL, Fan H, Wang H, Luber BS, et al. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 2015;5(1):43–51. doi:10.1158/2159-8290.CD-14-0863.
   PubMed Web of Science ®Google Scholar
• Masugi Y, Nishihara R, Yang J, Mima K, da Silva A, Shi Y, Inamura K, Cao Y, Song M, Nowak JA, et al. Tumour CD274 (PD-L1) expression and T cells in colorectal cancer. Gut. 2017;66(8):1463–1473. doi:10.1136/gutjnl-2016-311421.
   PubMed Web of Science ®Google Scholar
• Lasry A, Zinger A, Ben-Neriah Y. Inflammatory networks underlying colorectal cancer. Nat Immunol. 2016;17(3):230–240. doi:10.1038/ni.3384.
   PubMed Web of Science ®Google Scholar
• Maby P, Tougeron D, Hamieh M, Mlecnik B, Kora H, Bindea G, Angell HK, Fredriksen T, Elie N, Fauquembergue E, et al. Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy. Cancer Res. 2015;75(17):3446–3455. doi:10.1158/0008-5472.CAN-14-3051.
   PubMed Web of Science ®Google Scholar
• Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.. Am J Pathol. 1994;145:148–156.
   PubMed Web of Science ®Google Scholar
• Smyrk TC, Watson P, Kaul K, Lynch HT. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer. 2001;91(12):2417–2422. doi:10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U.
   PubMed Web of Science ®Google Scholar
• Dolcetti R, Viel A, Doglioni C, Russo A, Guidoboni M, Capozzi E, Vecchiato N, Macrì E, Fornasarig M, Boiocchi M, et al. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol. 1999;154(6):1805–1813. doi:10.1016/S0002-9440(10)65436-3.
   PubMed Web of Science ®Google Scholar
• Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T, Bruneval P, Trajanoski Z, Fridman W-H, Pagès F, et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol. 2011;29(6):610–618. doi:10.1200/JCO.2010.30.5425.
   PubMed Web of Science ®Google Scholar
• Angell H, Galon J. From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer. Curr Opin Immunol. 2013;25(2):261–267. doi:10.1016/j.coi.2013.03.004.
   PubMed Web of Science ®Google Scholar
• Hardy MP, Vincent K, Perreault C. The Genomic Landscape of Antigenic Targets for T Cell-Based Leukemia Immunotherapy. Front Immunol. 2019;10:2934. doi:10.3389/fimmu.2019.02934.
   PubMed Web of Science ®Google Scholar
• Luo X, Huang R, Sun H, Liu Y, Bi H, Li J, Yu H, Sun J, Lin S, Cui B, et al. Methylation of a panel of genes in peripheral blood leukocytes is associated with colorectal cancer. Scientific Reports. 2016;6(1):29922. doi:10.1038/srep29922.
   PubMed Web of Science ®Google Scholar
• Papadia C, Louwagie J, Del Rio P, Grooteclaes M, Coruzzi A, Montana C, Novelli M, Bordi C, De’ Angelis GL, Bassett P, et al. FOXE1 and SYNE1 genes hypermethylation panel as promising biomarker in colitis-associated colorectal neoplasia. Inflamm Bowel Dis. 2014;20(2):271–277. doi:10.1097/01.MIB.0000435443.07237.ed.
   PubMed Web of Science ®Google Scholar
• Rasmussen SL, Krarup HB, Sunesen KG, Johansen MB, Stender MT, Pedersen IS. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection. PLoS One. 2017;12:e0180809.
   Google Scholar
• Ramos-Molina B, Sanchez-Alcoholado L, Cabrera-Mulero A, Lopez-Dominguez R, CarmonaSaez P, Garcia-Fuentes E, et al. Gut Microbiota Composition Is Associated With the Global DNA Methylation Pattern in Obesity. Front Genet. 2019;10:613. doi:10.3389/fgene.2019.00613
   PubMed Web of Science ®Google Scholar
• Hurtado CG, Wan F, Housseau F, Sears CL. Roles for Interleukin 17 and Adaptive Immunity in Pathogenesis of Colorectal Cancer. Gastroenterology 2018;155:1706–15 6 doi:10.1053/j.gastro.2018.08.056
   PubMed Web of Science ®Google Scholar
• Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013; 342:971–6
   PubMed Web of Science ®Google Scholar
• Hsu P-C, Kadlubar SA, Siegel ER, Rogers LJ, Todorova VK, Su LJ, Makhoul I. Genome-wide DNA methylation signatures to predict pathologic complete response from combined neoadjuvant chemotherapy with bevacizumab in breast cancer. PLoS One. 2020;15(4):e0230248. doi:10.1371/journal.pone.0230248.
   PubMed Web of Science ®Google Scholar
• Hernandez Puente CV, Hsu P-C, Rogers LJ, Jousheghany F, et al. Association of DNA-Methylation Profiles With Immune Responses Elicited in Breast Cancer Patients Immunized With a Carbohydrate-Mimicking Peptide: A Pilot Study. Front Oncol. 2020;10:879. doi:10.3389/fonc2020.
   Google Scholar
• Kalekar LA, Schmiel SE, Nandiwada SL, Lam WY, Barsness LO, Zhang N, Stritesky GL, Malhotra D, Pauken KE, Linehan JL. CD4+ T cell anergy prevents autoimmunity and generates regulatory T cell precursors. Nat Immunol. 2016;17(3):304–314. doi:10.1038/ni.3331.
   PubMed Web of Science ®Google Scholar
• Kumar H, Lund R, Laiho A, et al. Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis. MBio. 2014; 5.Dec 16;5(6):e02113-14. doi: 10.1128/mBio.02113-14.
   Google Scholar
• Guan Z, Raut JR, Weigl K, Schottker B, Holleczek B, Zhang Y, Brenner H. Individual and joint performance of DNA methylation profiles, genetic risk score and environmental risk scores for predicting breast cancer risk. Mol Oncol. 2020;14:42–53. doi:10.1002/1878-0261.12594.
   PubMed Web of Science ®Google Scholar
• Song X, Sun X, Oh SF, Wu M, Zhang Y, Zheng W, Geva-Zatorsky N, Jupp R, Mathis D, Benoist C. Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis. Nature. 2020;577(7790):410–415. doi:10.1038/s41586-019-1865-0.
   PubMed Web of Science ®Google Scholar
• Hang S, Paik D, Yao L, Kim E, Trinath J, Lu J, Ha S, Nelson BN, Kelly SP, Wu L, et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature. 2019;576(7785):143–148. doi:10.1038/s41586-019-1785-z.
   PubMed Web of Science ®Google Scholar